On Thursday, August 14, stocks bounced back after declining earlier in the day. Investors decided to buy the dip, even though July’s producer price index (PPI) reading suggested that a Federal Reserve ...

Investing in biotechnology stocks is typically reserved for speculative investors. For starters, many of these companies are clinical or pre-clinical stage companies. They’re not yet profitable, and ...